Experts speak on tackling COVID-19

Coronavirus | Does SARS-CoV-2 affect the liver?

Dr. Harikumar R. Nair, Senior Consultant Hepatologist, Liver Transplant Physician. Photo: Special Arrangement  

There have been few predecessor viruses for this one, which share similarities in structure and in the way it inflicts damage to human body. Viruses self-mutate periodically, change its structure and form and take new avatars. The current avatar inducing COVID-19 spreads rapidly and has more death rate than previous generations. All previous coronaviruses were respiratory pathogens.

Liver impairment has been reported in up to 60% of patients with the preceding coronavirus — SARS-CoV. Given the fact that this novel corona (SARS-CoV-2) has 80% genetic similarity to the preceding strain of the virus (SARS-CoV), does it act similarly with reference to the liver?

Let us look at information from China. Liver damage in mild cases of COVID-19 is often temporary and the organ can return to normal without any special treatment. This could be due to the state of direct infection of liver cells or could as well be due to liver cells getting caught up in the immune war between body’s immune system and the virus with chemicals produced by our body, namely cytokines. More patients with severe disease had abnormal liver function tests than did non-severe patients with COVID. Those who tested positive for the virus (sub-clinical phase, identified by contact tracing), but did not develop symptoms had much less involvement of the liver. In short, liver injury depends on severity of COVID-19.

Cases of acute liver failure have not been reported yet from China or from other countries.

What about people who already have liver disease? People with non-alcoholic fatty liver disease (NAFLD) or its more severe form, non-alcoholic steatohepatitis (NASH), often have cardiovascular risk factors, including metabolic syndrome, obesity and diabetes, raising the risk for severe COVID-19 complications.

Although hepatitis B virus (HBV) is common in China and other Asian countries, studies so far have not reported whether HBV-related liver disease influences COVID-19 outcomes. All these liver diseases without advanced scarring or cirrhosis would not have more chance to get the virus infection though.

That is not the case with cirrhosis of liver — cirrhosis per se may be considered an immune dysfunctional state; those under medical management and those in whom a liver transplant is planned and waiting for organ allocation should also be considered at more risk.

Pre-existing disease

Those who have pre-existing liver disease, should they undergo check-up and LFTs to see if coronavirus has entered the liver? The answer is an emphatic NO. What has been mentioned here is abnormality of LFT in those patients who already developed COVID-19. COVID is a respiratory illness and will have symptoms pertaining to lung. Severe cases who are hospitalised alone may develop jaundice. Liver injury will not occur in the absence of respiratory illness and hence no screening tests/ LFT are indicated in patients with liver disease.

Are liver transplant recipients at higher risk for COVID-19?

Certainly. Those who have undergone liver transplant and are on immunosuppression medicines (anti-rejection medicines) are certainly at higher risk of getting this infection and logically, can end up with severe disease.

People with a weakened immune system may be unable to fight off the virus. So transplant patients have more chance of getting the virus, but paradoxically transplant recipients may not exhibit symptoms — fever, breathlessness — to begin with. Apart from the routine measures of frequent hand washing, hand sanitising, cough etiquette and avoiding putting hands to mouth, they should try to avoid crowds and non-essential travel.

Our code of editorial values

Related Topics
This article is closed for comments.
Please Email the Editor

Printable version | Jun 15, 2021 1:04:02 AM |

In This Series
Dr. Rahul Yadav on COVID-19 in neonates and infants
Non-COVID-19 emergencies in pandemic times
The role of palliative care
Lessons to follow after lockdown
You are reading
Coronavirus | Does SARS-CoV-2 affect the liver?
Judiciously managing brain tumour patients
Don’t ignore abdominal symptoms
It’s important to protect skin
Private sector and patient safety
COVID-19: The tests reveal all
Will Vitamin C be of any help?
COVID-19 and the nervous system
Coronavirus and diabetes | Can DPP-4 inhibitors play a role?
Masks are mandatory for all now
Stroke is an exception, rush to hospital
COVID-19 enhances reliance on telemedicine
‘How I fought COVID-19 and won!’
Coronavirus | What is convalescent plasma therapy?
Palliative care is the answer
Testing strategies for the virus
COVID-19: Breathing hard
Some tips to avoid diabetic amputations during lockdown
The virus versus women
Retaining the humanitarian approach in times of COVID-19
Do not ignore non-COVID-19 medical emergencies
In search of Vitamin D this summer of lockdown
Be alert, not anxious
Postponing elective surgeries can save lives
Sensitising parents of children with special needs
Aches and pains and a spot of exercise during COVID-19
Coronavirus | Managing pregnancy and childbirth
Coronavirus | Step up checking virus in patients, says virologist Jacob John
Boosting immunity is need of the hour
A look into key aspects of virus pandemic
COVID-19’s gut connection
Fighting a virus with dedicated health cadre
COVID-19 | Will it be polite with children?
Lessons from a pandemic: It’s OK to be smart
Does COVID-19 have a link with the eyes?
Sleepless during a pandemic: Insomnia going viral
Because the mind matters
Coronavirus | Are diabetics more prone to COVID-19?
What does COVID-19 mean for kidneys?
Next Story